Le Lézard
Classified in: Business
Subject: STOCK/OTHER MARKET NEWS

Charles Bachtell Announces Holdings in Cresco Labs Inc.


CHICAGO, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Charles Bachtell announced today that, in connection with the business combination (the "Business Combination") completed on November 30, 2018 among certain parties, including Cresco Labs Inc. (the "Company") and Cresco Labs, LLC ("Cresco"), Mr. Bachtell, directly or indirectly, acquired ownership of:

Following the Business Combination, Mr. Bachtell and the entities under the control and direction of Mr. Bachtell continue to hold an aggregate of  16,243,185 units of Cresco (the "Redeemable Units"), which are ultimately convertible into 16,243,185 Subordinate Voting Shares of the Company.

Immediately prior to the completion of the Business Combination, Mr. Bachtell did not own or exercise control or direction over any securities of the Company. The Proportionate Voting Shares and Redeemable Units represent, on an as-converted to Subordinate Voting Share-basis, 44.17% of the issued and outstanding Subordinate Voting Shares (assuming the conversion only of those convertible securities held by Mr. Bachtell and not of any other convertible securities of the Company), and 6.41% of outstanding Subordinate Voting Shares on a fully diluted basis.

Mr. Bachtell holds and controls his shares of the Company for investment purposes only and Mr. Bachtell may increase or decrease his beneficial ownership or control over the shares of the Company, which he may do, from time to time, depending on market or other conditions and to the extent deemed advisable in light of his general investment strategy. The Super Voting Shares held by Mr. Bachtell and certain other founders of Cresco are designed to ensure that such individuals have voting control at meetings of shareholders of the Company. The Super Voting Shares are subject to the provisions of the investment agreement among the Company, Mr. Bachtell, and such other founders, as described in the Company's listing statement dated November 30, 2018, which is posted and filed under the Company's profile on www.sedar.com.

This news release is being disseminated as required by National Instrument 62-103 - The Early Warning System and Related Take-Over Bids and Insider Reporting Issues in connection with the anticipated filing of an early warning report (the "Early Warning Report"). A copy of the Early Warning Report will be available on SEDAR under the Company's issuer profile at www.sedar.com and can be obtained by contacting the Company as set out below.

For further information please contact:

John Schetz, General Counsel, Cresco Labs Inc.
520 W Erie St #220,
Chicago, IL 60654
USA

Phone: (312) 410-8226
Email: [email protected]


These press releases may also interest you

at 20:55
Quorum Information Technologies Inc. ("Quorum"), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment Manufacturers ("OEMs") rely on for their operations,...

at 20:50
Rogers Communications Inc. ("Company"), in accordance with Toronto Stock Exchange requirements, announced the voting results from its Annual and Special Meeting of Shareholders (meeting) held earlier today. Shareholders voted for all items of...

at 20:16
Evolution Equity Partners announced the final closing of Evolution Technology Fund III, LP on April 16th, 2024, and total capital commitments of $ 1.1 Billion to back visionary entrepreneurs building next generation...

at 20:05
Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the three months ended March 31, 2024. Summary of Consolidated Financial Results (Note 1) Summary of Consolidated Financial...

at 20:00
Pulse Seismic Inc. ("Pulse" or the "Company") is pleased to report its financial and operating results for the three months ended March 31, 2024. The unaudited condensed consolidated interim financial statements, accompanying notes and MD&A are...

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...



News published on and distributed by: